NORTHERN TRUST CORP - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 81 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$93,000
-83.9%
96,658
-80.2%
0.00%
Q1 2022$579,000
-66.2%
487,083
-7.2%
0.00%
Q4 2021$1,711,000
-27.0%
524,880
+0.0%
0.00%
Q3 2021$2,345,000
-22.4%
524,679
-5.4%
0.00%
-100.0%
Q2 2021$3,022,000
-22.3%
554,422
+6.6%
0.00%0.0%
Q1 2021$3,890,000
-20.6%
519,905
+15.1%
0.00%0.0%
Q4 2020$4,902,000
+20.1%
451,788
-2.2%
0.00%0.0%
Q3 2020$4,082,000
-22.2%
461,835
-6.1%
0.00%0.0%
Q2 2020$5,245,000
+117.2%
491,975
+20.8%
0.00%0.0%
Q1 2020$2,415,000
-12.9%
407,341
+1.5%
0.00%0.0%
Q4 2019$2,774,000
-37.4%
401,501
-5.9%
0.00%0.0%
Q3 2019$4,431,000
+44.2%
426,851
+28.7%
0.00%0.0%
Q2 2019$3,072,000
+9.7%
331,646
+8.2%
0.00%0.0%
Q1 2019$2,801,000
+64.3%
306,454
+0.1%
0.00%
Q4 2018$1,705,000
-52.9%
306,167
+0.7%
0.00%
-100.0%
Q3 2018$3,620,000
+28.6%
303,988
+10.3%
0.00%0.0%
Q2 2018$2,814,000
+19.7%
275,638
+52.2%
0.00%0.0%
Q1 2018$2,351,000
+80.2%
181,090
+35.0%
0.00%
Q4 2017$1,305,000
-34.9%
134,163
-1.5%
0.00%
-100.0%
Q3 2017$2,006,000
+114.5%
136,264
+134.7%
0.00%
Q2 2017$935,000
+77.4%
58,070
+75.4%
0.00%
Q1 2017$527,000
+60.2%
33,098
+22.4%
0.00%
Q4 2016$329,00027,0480.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 881,450$5,677,0001.32%
IFP Advisors, Inc 50$1,0000.00%
Ten Capital Wealth Advisors, LLC 219$1,0000.00%
View complete list of SYROS PHARMACEUTICALS INC shareholders